List of Contents

Antibody Production Market Size, Share, and Trends 2024 to 2034

The global antibody production market size is calculated at USD 24.80 billion in 2024, grew to USD 28.04 billion in 2025, and is predicted to hit around USD 84.72 billion by 2034, poised to grow at a CAGR of 13.07% between 2024 and 2034. The North America antibody production market size accounted for USD 9.92 billion in 2024 and is anticipated to grow at the fastest CAGR of 13.21% during the forecast year.

  • Last Updated : October 2024
  • Report Code : 3212
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Antibody Production Market 

5.1. COVID-19 Landscape: Antibody Production Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Antibody Production Market, By Product

8.1. Antibody Production Market Revenue and Volume Forecast, by Product, 2024-2034

8.1.1. Instruments

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Consumables

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Software

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Antibody Production Market, By Process

9.1. Antibody Production Market Revenue and Volume Forecast, by Process, 2024-2034

9.1.1. Upstream Processing

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Downstream Processing

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Antibody Production Market, By Type 

10.1. Antibody Production Market Revenue and Volume Forecast, by Type, 2024-2034

10.1.1. Monoclonal Antibody

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Polyclonal Antibody

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Antibody Production Market, By End-use 

11.1. Antibody Production Market Revenue and Volume Forecast, by End-use, 2024-2034

11.1.1. Pharmaceutical and Biotechnology Companies

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Research Laboratories

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. CROs and CDMOs

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Antibody Production Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.1.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.1.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.1.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.1.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.1.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.1.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.2.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.2.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.2.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.2.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.2.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.2.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.2.7.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.2.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.7.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.2.8.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.2.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.8.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.3.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.3.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.3.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.3.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.3.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.3.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.3.7.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.3.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.7.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.3.8.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.3.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.4.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.4.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.4.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.4.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.4.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.4.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.4.7.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.4.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.7.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.4.8.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.4.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.5.5.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.5.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.5.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

12.5.6.2. Market Revenue and Volume Forecast, by Process (2021-2034)

12.5.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2034)

Chapter 13. Company Profiles

13.1. QIAGEN

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Thermo Fisher Scientific, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. PerkinElmer, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. BGI

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Illumina, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Agilent Technologies

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Pacific Biosciences of California, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. ProPhase Labs, Inc. (Nebula Genomics)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Psomagen

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Azenta US, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us